agent

DEVICE3 trials

Sponsors

Peking University Cancer Hospital, Chinese PLA General Hospital, Translumina GmbH

Conditions

Coronary Artery DiseaseDrug Eluting BalloonDrug Eluting StentProstate cancercolorectal liver metastasis

Early Phase 1

Application of aluminum fluoride-labeled PSMA positron imaging agent in prostate tumors

RecruitingChiCTR2100053507

Chinese PLA General HospitalProstate cancer

Start: 2020-09-28Updated: 2022-10-04

Phase 4

Comparison of Ultrasound Contrast Agent Sonovue and Sonazoid in the Application of Colorectal Liver Metastasis: a Prospective Single Center Study

RecruitingChiCTR2000038055

Peking University Cancer Hospitalcolorectal liver metastasis

Start: 2020-09-01Updated: 2021-07-05

Unknown Phase

Stents Versus PAclitaxel Coated Balloons for Revascularization of CompleX and Small Coronary Vessels (SPARX) Trial

Not yet recruitingNCT07397845

Translumina GmbHCoronary Artery Disease, Drug Eluting Balloon, Drug Eluting Stent

Start: 2026-03-01End: 2029-04-01Target: 1380Updated: 2026-02-09

Related Papers

Synthesis, preclinical evaluation, and first-in-human study of Al<sup>18</sup>F-PSMA-Q for prostate cancer imaging.

2022-04-0910 citations